Second series of NeurATRIS/EATRIS webinars on tools for the study of neurodegenerative diseases

We are pleased to announce that EATRIS and NeurATRIS are launching a second series of webinars on neurodegenerative diseases in April-May of this year. The series will cover the usage of biological and technological tools such as preclinical models or ultra high field MRI in neurodegenerative diseases and their potential application in translational medicine. These webinars will be brought to you by experts in the field, each time in collaboration with a specialized European Research Infrastructure.

All webinars are free of charge. The webinars include an audience Q&A session during which attendees can ask questions at the end of the lecture. Please note that all webinars will be recorded and available for later viewing.

The first session of this series took place on April 17th at 11:00 AM and was jointly animated by EATRISNeurATRIS and Celphedia.

The second session will take place on May 6th at 11:00 AM and will be jointly animated by EATRIS, NeurATRIS and France Life Imaging.



Medical Research Infrastructures EATRIS, ECRIN and BBMRI sign long-term collaboration agreement

The Biobanking and BioMolecular resources Research Infrastructure (BBMRI), the European Research Infrastructure for Translational Medicine (EATRIS) and the European Clinical Research Infrastructure Network (ECRIN) signed an agreement last week in Brussels to build a long-term sustainable collaboration strategy. The agreement lays the ground for facilitating user access to pan-European medical research  infrastructures and supporting the development of tools, joint services and common approaches on quality, standards and advocacy. As a result, the agreement will empower BBMRI, EATRIS and ECRIN to provide even better services to the biomedical community and to support a more costeffective research and development process.


A member of NeurATRIS laureate 2018 of the Fondation Alzheimer

Benoît Larrat, researcher at Neurospin and member of NeurATRIS, is one of the 11 laureates 2018 of the Fondation Alzheimer with the TADUS project - Treating Alzheimer's Disease with Ultrasound.

More information about the project here.

"Mini-brains" for research on Alzheimer's disease

Researchers from SEPIA (François Jacob Institute of Biology) and CellTechs (Sup'Biotech engineering school), working in partnership with LEMM (Frédéric Joliot Institute for Life Sciences), all within or affiliated with the CEA, have developed a new approach for modeling Alzheimer's disease in vitro using human induced pluripotent stem cells (iPSCs). Their work builds upon the ability of iPSCs to differentiate into "mini-brains", that is, three-dimensional cellular structures recapitulating human brain development.